NRAS and primary cutaneous T-cell non-Hodgkin lymphoma: Cutaneous T-cell lymphomas (CTCLs) make up about 4% of non-Hodgkin lymphomas and the NRAS Q61K mutation in Hut78 cells has been determined as a significant oncogenic factor in CTCL development [16].